Sotera Health Company

XNASHealth care

Last traded price · USD

$16.39

+2.25%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 02:33 IST · A quote does not mean the product is available to trade on your account.

Day's open: $16.72
Previous close: $16.03
Volume: 4.6M
Day's high: $16.72
Day's low: $16.07

In brief

Sotera Health Company is a health care company listed on Nasdaq, valued at about $4.68B.
Its shares closed at $16.39 on 4 Nov 2026, down 0.2% over the past year.
From India you can buy SHC in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Sotera Health Company (SHC) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole SHC share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade SHC options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Below its 50- and 200-day averages
The 4 Nov 2026 close of $16.39 was 10.7% below its 50-day average ($18.36) and 3.4% below its 200-day average ($16.97). It has closed below the 200-day for 2 sessions, since 3 Nov 2026. The 50-day average crossed above the 200-day on 17 Jul 2026, 77 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
8.4 days to cover short interest
16.1M shares were sold short at the 15 Oct 2026 settlement, 5.6% of the 285.4M shares outstanding; covering them would take 8.4 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Behind SPY and its sector fund XLV over 1 year
1 month: −10.2% (SPY −1.6%, XLV +13.5%). 3 months: −8.8% (SPY −0.4%, XLV +15.5%). 1 year: −0.2% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: SHC, SPY and XLV · as of 4 Nov 2026
49% of the way up its 52-week range
Closed at $16.39 on 4 Nov 2026: 17.4% below the 52-week high of $19.85 (9 Jan 2026) and 25.2% above the low of $13.09 (30 Mar 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Volume 2.2× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 4.6M shares was 2.2× the average of the 30 sessions before it (2.1M), as the price rose 2.2%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−10.2%

6 months+3.7%

1 year−0.2%

5 years−38.4%

Newswire

About

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.

Website

Notable moves

January 10, 2023
+99.65%
November 21, 2022
+32.89%
September 19, 2022
−33.27%

Newswire

About

Website

Notable moves

January 10, 2023
+99.65%
November 21, 2022
+32.89%
September 19, 2022
−33.27%

Sotera Health Company

XNASHealth care

Last traded price · USD

$16.39

+2.25%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 02:33 IST · A quote does not mean the product is available to trade on your account.

Day's open: $16.72
Previous close: $16.03
Volume: 4.6M
Day's high: $16.72
Day's low: $16.07

In brief

Sotera Health Company is a health care company listed on Nasdaq, valued at about $4.68B.
Its shares closed at $16.39 on 4 Nov 2026, down 0.2% over the past year.
From India you can buy SHC in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Sotera Health Company (SHC) shares from India?

Do I need the price of a whole SHC share to invest?

How much can I invest in US stocks in a year?

Can I trade SHC options or futures?

Insights

Quotes run fifteen minutes behind.

Below its 50- and 200-day averages
The 4 Nov 2026 close of $16.39 was 10.7% below its 50-day average ($18.36) and 3.4% below its 200-day average ($16.97). It has closed below the 200-day for 2 sessions, since 3 Nov 2026. The 50-day average crossed above the 200-day on 17 Jul 2026, 77 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
8.4 days to cover short interest
16.1M shares were sold short at the 15 Oct 2026 settlement, 5.6% of the 285.4M shares outstanding; covering them would take 8.4 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Behind SPY and its sector fund XLV over 1 year
1 month: −10.2% (SPY −1.6%, XLV +13.5%). 3 months: −8.8% (SPY −0.4%, XLV +15.5%). 1 year: −0.2% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: SHC, SPY and XLV · as of 4 Nov 2026
49% of the way up its 52-week range
Closed at $16.39 on 4 Nov 2026: 17.4% below the 52-week high of $19.85 (9 Jan 2026) and 25.2% above the low of $13.09 (30 Mar 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Volume 2.2× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 4.6M shares was 2.2× the average of the 30 sessions before it (2.1M), as the price rose 2.2%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−10.2%

6 months+3.7%

1 year−0.2%

5 years−38.4%

Newswire

About

Website

Notable moves

January 10, 2023
+99.65%
November 21, 2022
+32.89%
September 19, 2022
−33.27%

Newswire

About

Website

Notable moves

January 10, 2023
+99.65%
November 21, 2022
+32.89%
September 19, 2022
−33.27%

Sotera Health Company

Sotera Health Company in brief

Below its 50- and 200-day averages

8.4 days to cover short interest

Behind SPY and its sector fund XLV over 1 year

49% of the way up its 52-week range

Volume 2.2× its 30-session average on 4 Nov 2026

Sotera Health Company

Sotera Health Company in brief

Below its 50- and 200-day averages

8.4 days to cover short interest

Behind SPY and its sector fund XLV over 1 year

49% of the way up its 52-week range

Volume 2.2× its 30-session average on 4 Nov 2026